Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA A Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys

In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzod...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 366; no. 1; p. 145
Main Authors Duke, Angela N, Meng, Zhiqiang, Platt, Donna M, Atack, John R, Dawson, Gerard R, Reynolds, David S, Tiruveedhula, V V N Phani Babu, Li, Guanguan, Stephen, Michael Rajesh, Sieghart, Werner, Cook, James M, Rowlett, James K
Format Journal Article
LanguageEnglish
Published United States 01.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzodiazepines), zolpidem (preferential binding to 1 subunit-containing GABA receptors), HZ-166 (8-ethynyl-6-(2'-pyridine)-4 -2,5,10b-triaza-benzo[ ]azulene-3-carboxylic acid ethyl ester; functionally selective with relatively high intrinsic efficacy for 2 and 3 subunit-containing GABA receptors), MRK-696 [7-cyclobutyl-6-(2-methyl-2 -1,2,4-triazol-2-ylmethoxy)-3-(2-flurophenyl)-1,2,4-triazolo(4,3- )pyridazine; no selectivity but partial intrinsic activity], and TPA023B 6,2'-diflouro-5'-[3-(1-hydroxy-1-methylethyl)imidazo[1,2- ][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile; partial intrinsic efficacy and selectivity for 2, 3, 5 subunit-containing GABA receptors]. We further examined the role of 1 subunit-containing GABA receptors in benzodiazepine-induced sedative effects by pretreating animals with the 1 subunit-preferring antagonist -carboline-3-carboxylate- -butyl ester ( CCT). Increasing doses of alprazolam and diazepam resulted in the emergence of observable ataxia, rest/sleep posture, and moderate and deep sedation. In contrast, zolpidem engendered dose-dependent observable ataxia and deep sedation but not rest/sleep posture or moderate sedation, and HZ-166 and TPA023 induced primarily rest/sleep posture. MRK-696 induced rest/sleep posture and observable ataxia. Zolpidem, but no other compounds, significantly increased tactile/oral exploration. The sedative effects engendered by alprazolam, diazepam, and zolpidem generally were attenuated by CCT pretreatments, whereas rest/sleep posture and suppression of tactile/oral exploration were insensitive to CCT administration. These data suggest that 2/3-containing GABA receptor subtypes unexpectedly may mediate a mild form of sedation (rest/sleep posture), whereas 1-containing GABA receptors may play a role in moderate/deep sedation.
AbstractList In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis. Using quantitative behavioral observation techniques in rhesus monkeys, we examined the effects of alprazolam and diazepam (nonselective benzodiazepines), zolpidem (preferential binding to 1 subunit-containing GABA receptors), HZ-166 (8-ethynyl-6-(2'-pyridine)-4 -2,5,10b-triaza-benzo[ ]azulene-3-carboxylic acid ethyl ester; functionally selective with relatively high intrinsic efficacy for 2 and 3 subunit-containing GABA receptors), MRK-696 [7-cyclobutyl-6-(2-methyl-2 -1,2,4-triazol-2-ylmethoxy)-3-(2-flurophenyl)-1,2,4-triazolo(4,3- )pyridazine; no selectivity but partial intrinsic activity], and TPA023B 6,2'-diflouro-5'-[3-(1-hydroxy-1-methylethyl)imidazo[1,2- ][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile; partial intrinsic efficacy and selectivity for 2, 3, 5 subunit-containing GABA receptors]. We further examined the role of 1 subunit-containing GABA receptors in benzodiazepine-induced sedative effects by pretreating animals with the 1 subunit-preferring antagonist -carboline-3-carboxylate- -butyl ester ( CCT). Increasing doses of alprazolam and diazepam resulted in the emergence of observable ataxia, rest/sleep posture, and moderate and deep sedation. In contrast, zolpidem engendered dose-dependent observable ataxia and deep sedation but not rest/sleep posture or moderate sedation, and HZ-166 and TPA023 induced primarily rest/sleep posture. MRK-696 induced rest/sleep posture and observable ataxia. Zolpidem, but no other compounds, significantly increased tactile/oral exploration. The sedative effects engendered by alprazolam, diazepam, and zolpidem generally were attenuated by CCT pretreatments, whereas rest/sleep posture and suppression of tactile/oral exploration were insensitive to CCT administration. These data suggest that 2/3-containing GABA receptor subtypes unexpectedly may mediate a mild form of sedation (rest/sleep posture), whereas 1-containing GABA receptors may play a role in moderate/deep sedation.
Author Dawson, Gerard R
Platt, Donna M
Stephen, Michael Rajesh
Meng, Zhiqiang
Atack, John R
Reynolds, David S
Tiruveedhula, V V N Phani Babu
Cook, James M
Rowlett, James K
Li, Guanguan
Sieghart, Werner
Duke, Angela N
Author_xml – sequence: 1
  givenname: Angela N
  surname: Duke
  fullname: Duke, Angela N
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 2
  givenname: Zhiqiang
  surname: Meng
  fullname: Meng, Zhiqiang
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 3
  givenname: Donna M
  surname: Platt
  fullname: Platt, Donna M
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 4
  givenname: John R
  surname: Atack
  fullname: Atack, John R
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 5
  givenname: Gerard R
  surname: Dawson
  fullname: Dawson, Gerard R
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 6
  givenname: David S
  surname: Reynolds
  fullname: Reynolds, David S
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 7
  givenname: V V N Phani Babu
  surname: Tiruveedhula
  fullname: Tiruveedhula, V V N Phani Babu
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 8
  givenname: Guanguan
  surname: Li
  fullname: Li, Guanguan
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 9
  givenname: Michael Rajesh
  surname: Stephen
  fullname: Stephen, Michael Rajesh
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 10
  givenname: Werner
  surname: Sieghart
  fullname: Sieghart, Werner
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 11
  givenname: James M
  surname: Cook
  fullname: Cook, James M
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.)
– sequence: 12
  givenname: James K
  surname: Rowlett
  fullname: Rowlett, James K
  email: jrowlett@umc.edu
  organization: New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts (A.N.D., Z.M., D.M.P., J.K.R.); Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi (D.M.P., J.K.R.); Medicines Discovery Institute, Cardiff University, Cardiff, Wales, United Kingdom (J.R.A.); P1Vital, University of Oxford, Warneford Hospital, Headington, Oxford, United Kingdom (G.R.D.); Alzheimer's Research UK, Granta Park, Great Abington, Cambridge, United Kingdom (D.S.R.); Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin (V.V.N.P.B.T., G.L., M.R.S., J.M.C.); and Division of Biochemistry and Molecular Biology, Center for Brain Research, Medical University of Vienna, Vienna, Austria (W.S.) jrowlett@umc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29720564$$D View this record in MEDLINE/PubMed
BookMark eNo1kMtOAjEYhRujkYuu3Zm-ANjbXOpuMIgkGCLgmnQ6f0MROpNpZyK8hW_sJOjqnOR8-RZngK5d6QChB0rGlDLxtK8gdC0dMyFZRK5Qn0aMjgglvIcG3u8JoULE_Bb1mEwYiWLRRz_T1hbgNODNTgW8hkIF2wKeGgM6eFwaPAF3LgurzlBZBx7PXVseOuTTwXfVQVDgWTbJcIZXoKEKZY3XTR5OFfhn_NEoF2y4SJe5h7rteunwOjSF7WzW4dUOfOPxe-m-4OTv0I1RBw_3fzlEm9fp5uVttFjO5i_ZYlRJHkYGjEwSzlIVS5XGQppcaw3cEKZ4IpQiRlPWzXmRmBwKJhKeSAEyZTqKTcyH6PGirZr8CMW2qu1R1aft_zX8F_3CaaY
ContentType Journal Article
Copyright Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
Copyright_xml – notice: Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1124/jpet.118.249250
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
ExternalDocumentID 29720564
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: R01 DA033795
– fundername: NCRR NIH HHS
  grantid: K26 RR000168
– fundername: NIDA NIH HHS
  grantid: R01 DA011792
– fundername: NCRR NIH HHS
  grantid: P51 RR000168
– fundername: NIDA NIH HHS
  grantid: R01 DA043204
– fundername: NINDS NIH HHS
  grantid: R01 NS076517
– fundername: NIAAA NIH HHS
  grantid: R01 AA016179
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
8WZ
A6W
AALRI
AAXUO
AAYOK
ABCQX
ABIVO
ABJNI
ABOCM
ABSQV
ACGFO
ACGFS
ACNCT
ADBBV
ADCOW
ADIYS
AENEX
AERNN
AETEA
AFFNX
AFOSN
AGFXO
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
F9R
FDB
GX1
H13
HZ~
INIJC
KQ8
L7B
LSO
M41
MJL
MVM
NPM
O9-
OHT
P2P
R.V
R0Z
RHI
ROL
RPT
TR2
UQL
VH1
W8F
WH7
WOQ
X7M
YBU
YHG
YQT
ZGI
ZXP
ID FETCH-LOGICAL-p93t-fef977328a69a8649fbccce3f02a374aa0fc1228abd7fbed2473794e982c56f63
IngestDate Sat Mar 08 01:25:24 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p93t-fef977328a69a8649fbccce3f02a374aa0fc1228abd7fbed2473794e982c56f63
PMID 29720564
ParticipantIDs pubmed_primary_29720564
PublicationCentury 2000
PublicationDate 2018-07-00
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 2018-07-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationTitleAlternate J Pharmacol Exp Ther
PublicationYear 2018
SSID ssj0014463
Score 2.369033
Snippet In nonhuman primates we tested a new set of behavioral categories for observable sedative effects using pediatric anesthesiology classifications as a basis....
SourceID pubmed
SourceType Index Database
StartPage 145
SubjectTerms Animals
Behavior, Animal - drug effects
Benzodiazepines - pharmacology
Female
Hypnotics and Sedatives - pharmacology
Macaca mulatta
Male
Receptors, GABA-A - metabolism
Title Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABA A Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys
URI https://www.ncbi.nlm.nih.gov/pubmed/29720564
Volume 366
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWGsmGDeD8K6C5QNzRlxs4kDrsUChUIaEuQuqsc22EqtUlgEiTmL_gdvo5747w6gARsoihWHCnn6L58H4w9RhUnpA45kpcHni9T4ykTICBSziOj5UxLKnB--y7Y_-i_Pp4fTyY_RllLdZXu6NVv60r-B1V8hrhSlew_INtvig_wHvHFKyKM17_CuBsJ-iRZoJ__wRrXxXtvyNHYtfmqQAqsbEn57dRWozj7SqYmtfbXZG6-inepOB3tR1uiA06ihOKyTarcYa3ypgqNtn2f9hHcLv2QoiVHC7uslyQcUB4sx8buUHbWGLzl0CXbNX26MF1gVAg2zLqvXepQTJm3ajg1olTc5lRlcfoZ6f2pl-9nyp11vSjyXA2B3rhSTuo3eUJH40jHTPZZsaioWunMKfYxFWPxLdzUlgs8dcJ45hpV_qokuE9KAr0SvJc71DPRNb8dUaY8bzjDo5CjiegP2rLPYeyWLrHLHF0Ump7x5nA4wUI3W7StpPB7T9e-Rj2o2_fX_JnGrkmusastPhA7dl1nE5vfYFsHDqtv25CMcNmGLTgYoXiTfe8oCERB6CgILQWhyGCNgtBSEAYKAlEQYugoCB0Fn8GYgDAiILQEhNMcHAGhJeAtlrzcS57ve-2UD6-MROVlNkMXRHCpgkjJwI-yVGttRTblSoS-UtNMzzgupybMUmu4HwrUITaSXM-DLBC32UZe5PYug1AYK20qjJkaP0il0jRFRvoi9XmI299jd9yfPildJ5eTDoP7f1zZZFcGKj5gG9WX2j5EM7RKHzV4_wRioJAP
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+That+Sedative+Effects+of+Benzodiazepines+Involve+Unexpected+GABA+A+Receptor+Subtypes%3A+Quantitative+Observation+Studies+in+Rhesus+Monkeys&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Duke%2C+Angela+N&rft.au=Meng%2C+Zhiqiang&rft.au=Platt%2C+Donna+M&rft.au=Atack%2C+John+R&rft.date=2018-07-01&rft.eissn=1521-0103&rft.volume=366&rft.issue=1&rft.spage=145&rft_id=info:doi/10.1124%2Fjpet.118.249250&rft_id=info%3Apmid%2F29720564&rft.externalDocID=29720564